In today's global pharmaceutical landscape, Medical Information (MI) teams must deliver timely, accurate, and compliant scientific responses across borders, time zones, and languages.
Healthcare professionals and patients expect accurate, evidence-based information delivered in their local language.
For MI leaders, multilingual capability is essential and it must be supported by a model designed to grow alongside expanding global portfolios.
MI bridges complex scientific data and real-world clinical decision-making. When delivered effectively, it strengthens confidence in therapies and supports compliance with regulatory and pharmacovigilance requirements.
As organizations expand into new markets, inquiry volumes grow across diverse regions and languages. This expansion introduces operational complexity:
Effective multilingual MI requires more than translation. Responses must be scientifically accurate, aligned with regulatory requirements, and consistent with global quality standards, while remaining responsive to local practices and expectations.
ProPharma delivers multilingual MI services through strategically positioned, globally integrated contact centers.
With support available in more than 35 languages, ProPharma's bilingual native-speaking specialists provide responses aligned with approved product labeling, regulatory guidance, and local communication norms. This ensures culturally consistent, scientifically accurate engagement with healthcare professionals and patients worldwide.
Integrated contact centers across North America, Europe, and Asia Pacific combine regional expertise with unified global oversight. This structure supports consistent scientific responses while aligning with regional healthcare systems, regulatory environments, and communication standards.
Operating across jurisdictions requires alignment with country-specific regulatory and data protection frameworks. ProPharma's regional capabilities incorporate local compliance considerations, including regional data privacy regulations such as China's Personal Information Protection Law (PIPL), while maintaining consistent global quality standards.
Globally integrated contact centers provide 24/7/365 MI support across time zones, ensuring responsiveness and continuity of service.
ProPharma develops, translates, and maintains Standard Response Documents and custom medical content in multiple languages. Delivered through globally integrated systems and supported by bilingual native-speaking specialists, this approach ensures consistent, accurate, and compliant MI aligned with local regulatory expectations.
Scalability in MI requires technology — but human expertise remains central.
ProPharma integrates AI-assisted workflows to support:
These tools enhance efficiency and responsiveness, while Medical Information Specialists validate outputs to ensure scientific accuracy, regulatory compliance, and alignment with local data privacy requirements.
A structured multilingual MI strategy delivers measurable impact:
MI inquiries are handled by trained specialists to ensure accurate, balanced, and compliant responses aligned with approved product information.
Services are delivered across North America, Europe, and Asia Pacific, with responses aligned to local regulatory requirements, healthcare systems, and communication practices.
With capabilities in more than 35 languages, new products, regions, and languages integrate seamlessly into established global operations.
MI services are supported by globally integrated systems that enable consistent documentation and oversight across regions.
For MI leaders, this balance provides confidence that growth can occur without compromising quality or compliance.
Multilingual Medical Information is essential to serving global healthcare communities effectively.
The right model:
By combining deep multilingual expertise with an integrated global operating model, ProPharma enables confident global scaling — supporting pharmaceutical companies, healthcare professionals, and patients worldwide.